Literature DB >> 21472095

Iatrogenic disease in the elderly: risk factors, consequences, and prevention.

Sompol Permpongkosol1.   

Abstract

The epidemiology of iatrogenic disease in the elderly has not been extensively reported. Risk factors of iatrogenic disease in the elderly are drug-induced iatrogenic disease, multiple chronic diseases, multiple physicians, hospitalization, and medical or surgical procedures. Iatrogenic disease can have a great psychomotor impact and important social consequences. To identify patients at high risk is the first step in prevention as most of the iatrogenic diseases are preventable. Interventions that can prevent iatrogenic complications include specific interventions, the use of a geriatric interdisciplinary team, pharmacist consultation and acute care for the elderly units.

Entities:  

Keywords:  elderly; iatrogenic disease; prevention; risk factors

Mesh:

Year:  2011        PMID: 21472095      PMCID: PMC3066256          DOI: 10.2147/CIA.S10252

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


Introduction

The definition of the term “elderly” varies widely in the medical literature, the most common lower limits being 60, 65, 70, 75, and 80 years.1 The term “elderly” comes from the Anglo-Saxon word “eld”, which forms the root of words that convey wisdom accrued from age and experience.2 The word “iatrogeny” derives from Greek and refers to any pathologic alteration caused to a patient by the inappropriate practice of health professionals, which results in harmful consequences for the patient’s health.3 According to the World Health Organisation, iatrogenic disease may be defined as adverse drug reactions or complications induced by nondrug medical interventions.4 In addition, iatrogenic disease has been defined by Darchy et al5 as a disease induced by a drug prescribed by a physician, after a medical or surgical procedure (excluding intentional overdose, nonmedical intervention) unauthorized prescription, and environmental events (eg, falls, defective equipment). However, it has to be kept in mind that, by definition, an adverse drug reaction differs from an adverse drug event, in that the former is an outcome attributable to a drug, whereas the latter, while associated with medication intake, is not necessarily so.6 Iatrogenic disease is an important cause of both death and illness among older people, and occurs in all aspects of medical practice, starting with the patient-doctor relationship, and including diagnosis, treatment, and, finally, prevention of disease.3 This article reviews the epidemiology, risk factors, consequences, and prevention of iatrogenic disease in the elderly.

Epidemiology

The epidemiology of iatrogenic disease in the elderly has not been precisely reported. However, it is possible to make estimates from previous publications related to iatrogenic disease. A recent meta-analysis showed the incidence of iatrogenic disease to be between 3.4% and 33.9%.4 In 1998, Darchy et al5 reported that of 623 patients admitted to the intensive care unit, 68 (10.9%) were considered to be iatrogenic cases. The causes of iatrogenic disease were drugs in 41 cases, medical interventions in 12, and surgical interventions in 15. Risk factors for iatrogenic disease were old age and the number of prescribed drugs. These iatrogenic complications included adverse drug effects (eg, interactions), falls, nosocomial infections, pressure areas, delirium, and complications related to surgery. In 2003, Peyriere et al7 reported that the rate of avoidability of adverse drug events as a cause for admission in internal medicine or when occurring during hospitalization was 57.9%. These adverse events were associated with therapeutic errors, such as inappropriate drug administration, drug–drug interactions, and dosage error. Patients with adverse drug events stayed longer in hospital and took more drugs, both before and during their hospital stay (P < 0.05). Recently, Mercier et al reported that 19.5% of intensive care unit admissions resulted from iatrogenic events, with a high proportion of shock, leading to a greater need for invasive treatments and longer stays in the intensive care unit.8 Epidemiological studies performed by pharmacists and epidemiologists produced lower incidences than those of internists. Atiqi et al reassessed the prevalence of iatrogenic admissions reported in a study done by internists.4 Most often, iatrogenic admissions were observed with cardiac disease, hypertension, gastrointestinal conditions, anticoagulant treatment, and use of nonsteroidal anti-inflammatory drugs. At least 19% of admissions were to departments of internal medicine, cardiology, and pulmonology, and up to 29% of these admissions were suspected to be attributable to adverse drug effects. Interestingly, a large difference was observed between the number of iatrogenic admissions according to the admitting physicians and the investigators (229 versus 380, respectively). Aranaz-Andres et al demonstrated that patients older than 65 years of age had a higher frequency of adverse events than those under this age (12.4% versus 5.4%, P < 0.001, relative risk 2.5) in Spanish hospitals.9 Studies of US patients aged over 65 years indicate that each year, more than 180,000 life-threatening or fatal adverse drug effects occur in the outpatient setting, of which at least half may be preventable.10 Finally, iatrogenic pathology in the elderly population has an even bigger impact due to the conjugation of two major demographic phenomena, ie, an absolute and percentage increase in the elderly population in parallel with an increased prevalence of iatrogenic pathology with age.11

Risk factors

Elderly patients have more comorbidities than their younger counterparts. An increased incidence of adverse drug events in elderly patients may be explained by the increased number of pathologies or disease states present in the elderly, and the number of drugs taken on a long-term basis, resulting in alteration in excretion and elimination processes (kidneys, liver) and changes in plasma protein levels (eg, hypoalbuminemia). This increased exposure to medical interventions increases the risk for adverse consequences of care. To identify patients at high risk is the first step in prevention, and most iatrogenic diseases are avoidable.7

Drug-induced iatrogenic disease

Multiple medications (polypharmacy) that transform the elderly into living “chemistry sets”, are probably the most ubiquitous threats for iatrogenic disease. In a study of elderly patients, a high number of daily drugs increased the risk of drug interactions responsible for iatrogenic illnesses in 12.6% of cases.12 Taking multiple drugs concurrently and having multiple chronic diseases markedly increase the risk of adverse drug–drug or drug–disease interactions. The risk of such interactions is particularly high among patients who are malnourished or who have renal failure.13 Also, certain drugs have a particularly high risk of causing adverse effects in the elderly. Several studies on falls in the elderly have reported that laxatives can be a risk factor. However, there is no proven causal link between laxative drugs and falls. A recent meta-analysis14 showed that elderly subjects treated with laxatives were twice as likely to fall compared with nonlaxative users. The causal relationship was probably not directly linked with a side effect of the substance used, but rather a reflection of other pathologies that may cause falls. These pathologies included older age, confinement to bed, or concomitant Parkinson’s disease.

Multiple chronic diseases

The greater the number of chronic diseases, the greater the risk that treatment of one disease will exacerbate other conditions. For example, treatment of arthritis with a non-steroidal anti-inflammatory drug may exacerbate heart failure, coronary artery disease, or chronic gastritis.13

Multiple physicians

Misdiagnosis, including both overtreatment and undertreatment, is a recurrent problem in the elderly. Having multiple physicians can result in uncoordinated care and unnecessary polypharmacy. As a result, a patient’s therapeutic regimen is frequently changed without the input of the patient’s other physicians, thereby increasing the risk of iatrogenic complications.13

Hospitalization

Hospitalization of nursing home residents is costly, and potentially exposes residents to iatrogenic disease and psychological harm.15 Jahnigen et al reported a disproportionately high incidence of iatrogenic diseases in hospitalized patients over the age of 65 years.16 Foster et al demonstrated that intensive care unit-based adverse events are common, and have a large impact on length of hospital stay.17 They estimated that adverse events were independently associated with an average increase in hospital stay of 31 days. This study reaffirms the importance of improving patient safety in the intensive care unit by monitoring the risk of adverse events.

Medical or surgical procedures

Several of the risks for iatrogenic disease are amenable to control. Risks due to hospitalization include hospital-acquired infection, polypharmacy, and transfusion reactions. Hospitalized patients who have dementia or who are immobilized (eg, after surgery) are at high risk of iatrogenic complications. Medical technology may contribute to iatrogenic complications, including sudden death or myocardial infarction after valve replacement surgery, stroke after carotid endarterectomy, fluid overload after transfusions and infusions, unwanted prolongation of life via artificial life support, and hypoxic encephalopathy after potentially life-prolonging cardiopulmonary resuscitation. For epidural anesthesia, Date et al reported that epidural catheters were misplaced in the subarachnoid space in six cases and in the thoracic cavity in two cases over a period of eight years (1999–2007) at an urban university hospital.18 In urology, Permpongkosol et al19 reported their experience with laparoscopic extravesical neoureterocystostomy for iatrogenic distal ureteral stricture using a transperitoneal intracorporeal freehand suturing technique. One patient, a 77-year-old male, underwent a Lich-Gregoir antireflux ureteral reimplantation following complications arising from transurethral resection of the prostate.

Consequences

In 1980, the World Health Organisation introduced a new system of classification related to the consequences of disease, known as the “International Classification of Impairments, Disabilities, and Handicaps”. Clinicians must know how iatrogenic disease presents in the elderly and how to manage it. Because one of the hallmarks of aging seems to be a loss of reserve capacity, and hence a loss of ability to respond to stress, many older persons may fail to exhibit the characteristic symptoms associated with a given disease. Moreover, most of the elderly suffer from several chronic conditions, making it difficult to distinguish clearly a symptom of iatrogenic disease in the context of coexisting problems. A diagnosis of iatrogenic disease thus requires a substantial degree of insight and subtlety. Iatrogenic disease can happen to anyone, especially amongst the elderly, and may have quite traumatizing psychomotor and social consequences. As a consequence of iatrogenic disease, the patient may become dependent on a third person, and may no longer be able to leave their home. Iatrogenic disease produced as a result of medical intervention may lead to confusion in certain cases during investigation and postmortem examination. For example, Chattopadhyay and Pal reported a rare case in which the iatrogenic injuries produced by a medical practitioner during the course of treatment of a case of suicidal hanging resulted in suspicion being raised as to the nature of the death.20

Prevention

A preventable event may be defined as an event that would not occur if medical science can provide optimal management. Prevention remains the best guarantee of good quality of life, and can decrease the social and economic costs of illness.21 However, older patients and those with a greater number of health problems have been shown to be at increased risk of preventable adverse events.22 Identification of the elderly who are at high risk, minimization of medication, early recognition and treatment of illness, and close management of chronic illness, are necessary components of preventive care. Mercier et al reported that 73.8% of iatrogenic events in their study of intensive care unit cases seemed preventable.8 The traditional tripartite division of prevention into primary, secondary, and tertiary prevention is difficult to maintain when considering the healthcare needs of older people.23,24 Primary prevention aims to stop iatrogenic disease before it starts, usually by reducing or eliminating risk factors. In secondary prevention, iatrogenic disease is detected and treated at an early stage, before symptoms or functional losses occur, thereby minimizing morbidity and mortality. In tertiary prevention, an existing symptomatic, usually chronic, iatrogenic disease is appropriately managed to prevent further functional loss. Iatrogenic disease is the most preventable problem among the elderly. Interventions that can prevent iatrogenic complications are now discussed.

Specific interventions

Up to 50% of adverse events that occur in hospitals are preventable. Care managers who facilitate communication among healthcare practitioners should ensure that the required services are provided, and prevent duplication of these services.13 Language barriers and disabilities that affect communication have been shown to decrease quality of care.22 Patients with communication problems appeared to be at highest risk for preventable adverse events. Interventions to reduce the risk for these patients need to be developed and evaluated. Some specific interventions to reduce iatrogenic disease have been tested. A randomized controlled trial showed that a letter from the general practitioner was highly effective in reducing benzodiazepine use among older people.24,25 Care managers may be employed by physician groups, health plans, or community or governmental organizations. The frail elderly benefit most from case management. Management of the hospitalized elderly must be multidisciplinary, and should take into account the particular clinical and therapeutic characteristics of such a population. To decrease the incidence of adverse drug events, better use of drugs is needed, especially in the elderly. Most iatrogenic disorders can be avoided by using simple precautions, ie, increased knowledge of contraindications, restriction of self-medication, and lowering the number of concomitant drugs.7 The implementation of a nursing education program may significantly decrease the incidence of iatrogenic urethral injury, thereby improving patient safety.26

Geriatric interdisciplinary team

The comprehensive multidimensional assessment of older people is one of the cornerstones of the specialty of geriatric medicine. A geriatric interdisciplinary team evaluates all of the patient’s needs, develops a coordinated care plan, and manages (or, along with the primary care physician, comanages) care. Because this intervention is resource-intensive, it is best reserved for very complex cases.13 With improved collaboration between physicians and healthcare practitioners who specialize in drug safety, physicians could become more aware of adverse drug events. In addition, close contact between patients and nurses allows nurses to play a leading role in the prevention and detection of adverse drug events.7 A study by Dos Santos and Ceolim27 suggests the importance of devising methods to encourage nursing professionals to report iatrogenic events accurately, as well as to create wards specifically for the elderly population. However, their report was not detailed and failed to indicate interventions which could prevent new occurrences. Blinderman raised the issue of opioid-related iatrogenic harm, and discusses what counts as medical error in these circumstances, suggesting that palliative care specialists have a unique responsibility to provide guidance and establish a standard of care that all clinicians should adhere to.28

Pharmacist consultation

A pharmacist can help to minimize the potential complications caused by polypharmacy and inappropriate drug use.13 The authors of a previous meta-analysis urged prescribers to change their habits with respect to the management of constipation in elderly subjects.14 The risk/benefit ratio of the drugs administered could be improved with better knowledge of the patients’ medical histories and risk factors for adverse drug events.7 Clinical guidelines are often based on the results of clinical trials conducted in young subjects with a lower level of disease complexity.29 Therefore, the recommendations of clinical guidelines may be difficult to apply to older adults. Fusco et al presented a rationale and methodology in CRIME (the Development of CRIteria to assess appropriate Medication use among the Elderly), translating the recommendations of general clinical guidelines to this type of patient.29 As well as being alert to the possibility of new iatrogenic problems, it is also prudent to reassess a patient’s entire drug regimen at least twice a year, including categories often overlooked by patients and doctor, ie, drugs bought over the counter and “nutraceuticals”, such as herbal remedies or dietary supplements.10

Acute care for the elderly units

Traditionally, acute medical care has been insufficient to meet the complex care needs of frail older adults.30 These units are in hospital wards with protocols to ensure that elderly patients are thoroughly evaluated for potential iatrogenic problems before they occur, and any such problems are identified and appropriately managed.13 Ahmed and Pearce showed acute care for the elderly units to be associated with positive global outcomes (eg, cost, length of stay, readmission rates, utilization, rehabilitation, cognition, function, patient/staff satisfaction). Further research has pointed to a decreased incidence of delirium and polypharmacy.30 Ou et al31 reported that a surgeon’s expertise in biliary surgery, preoperative imaging, precise operative procedures, and conversion from laparoscopic to open cholecystectomy when needed, are important measures to prevent common bile duct injuries. Iatrogenic urethral injuries are a substantial source of preventable morbidity in hospitalized male patients. The implementation of a nursing education program may significantly decrease the incidence of iatrogenic urethral injury and, thereby improve patient safety.26 Bunting et al31 published an article to equip physicians with an adequate working knowledge of risk management and quality management information, which will enable them to practice more effectively in today’s litigious and regulatory climate.32 Patients are encouraged to prepare advance directives, including designation of a proxy to make medical decisions.13 These documents can help prevent unwanted treatment for critically ill patients who cannot speak for themselves.

Conclusion

Iatrogenic disease in the elderly population has a particularly significant impact due to the conjugation of major demographic phenomena. Multiple drugs, multiple physicians, multiple chronic diseases, hospitalization, and disease arising from medical or surgical procedures increase the risk of iatrogenic disease in the elderly. Iatrogenic disease may have a significant psychomotor impact and devastating social consequences. Interventions that can prevent iatrogenic complications include a geriatric interdisciplinary team, pharmacist consultation, acute care for the elderly units, and advance directives.
  31 in total

1.  Practical risk management principles for physicians.

Authors:  R F Bunting; J Benton; W D Morgan
Journal:  J Healthc Risk Manag       Date:  1998

Review 2.  Predictors of nursing home hospitalization: a review of the literature.

Authors:  David C Grabowski; Kate A Stewart; Suzanne M Broderick; Laura A Coots
Journal:  Med Care Res Rev       Date:  2008-02       Impact factor: 3.929

3.  Adverse Drug Reactions in Elderly People: A substantial cause of preventable illness.

Authors:  Jerry Avorn; William H Shrank
Journal:  BMJ       Date:  2008-04-08

Review 4.  [Iatrogeny and the elderly].

Authors:  G Ungureanu; Ioana Dana Alexa; Ortansa Stoica
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2007 Oct-Dec

5.  Iatrogenic injuries leading to suspicion of homicide.

Authors:  Saurabh Chattopadhyay; Indranil Pal
Journal:  J Forensic Leg Med       Date:  2008-07-11       Impact factor: 1.614

Review 6.  A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carers.

Authors:  A Mason; H Weatherly; K Spilsbury; H Arksey; S Golder; J Adamson; M Drummond; C Glendinning
Journal:  Health Technol Assess       Date:  2007-04       Impact factor: 4.014

7.  Incidence and prevention of iatrogenic urethral injuries.

Authors:  Carol Kashefi; Karen Messer; Rita Barden; Carolyn Sexton; J Kellogg Parsons
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 8.  Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis.

Authors:  Roland Schmitt; Steven Coca; Mehmet Kanbay; Mary E Tinetti; Lloyd G Cantley; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2008-05-29       Impact factor: 8.860

9.  Impact of patient communication problems on the risk of preventable adverse events in acute care settings.

Authors:  Gillian Bartlett; Régis Blais; Robyn Tamblyn; Richard J Clermont; Brenda MacGibbon
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

10.  Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events.

Authors:  J M Aranaz-Andrés; C Aibar-Remón; J Vitaller-Murillo; P Ruiz-López; R Limón-Ramírez; E Terol-García
Journal:  J Epidemiol Community Health       Date:  2008-12       Impact factor: 3.710

View more
  18 in total

1.  Optimizing pharmacotherapy in older patients: a European perspective.

Authors:  Denis O'Mahony; Antonio Cherubini; Mirko Petrovic
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy.

Authors:  Roy L Soiza; Selvarani Subbarayan; Cherubini Antonio; Alfonso J Cruz-Jentoft; Mirko Petrovic; Adalsteinn Gudmundsson; Denis O'Mahony
Journal:  Ther Adv Drug Saf       Date:  2016-11-02

3.  Prescription errors in geriatric patients can be avoided by means of a computerized physician order entry (CPOE).

Authors:  S Frisse; G Röhrig; J Franklin; M C Polidori; R-J Schulz
Journal:  Z Gerontol Geriatr       Date:  2015-06-11       Impact factor: 1.281

Review 4.  Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition.

Authors:  Carmelo Scarpignato; Ingvar Bjarnason
Journal:  Curr Gastroenterol Rep       Date:  2019-11-13

5.  Becoming a nonagenarian: factors associated with survival up to 90 years old in 70+ men and women. Results from the PAQUID longitudinal cohort.

Authors:  A Edjolo; C Helmer; P Barberger-Gateau; J-F Dartigues; C Maubaret; K Pérès
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

6.  Rehabilitation Nutrition for Iatrogenic Sarcopenia and Sarcopenic Dysphagia.

Authors:  A Nagano; S Nishioka; H Wakabayashi
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

7.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

8.  National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Nancy Kim; Jeptha P Curtis; Mayur M Desai; Harlan M Krumholz
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

9.  Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride.

Authors:  Antonino Catalano; Gabriella Martino; Federica Bellone; Maria Papalia; Carmen Lasco; Giorgio Basile; Alberto Sardella; Giacomo Nicocia; Nunziata Morabito; Antonino Lasco
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

Review 10.  Effectiveness of acute geriatric unit care using acute care for elders components: a systematic review and meta-analysis.

Authors:  Mary T Fox; Malini Persaud; Ilo Maimets; Kelly O'Brien; Dina Brooks; Deborah Tregunno; Ellen Schraa
Journal:  J Am Geriatr Soc       Date:  2012-11-23       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.